Posts

Posted on

TiVo and Cox Communications Extend IP Agreement

TiVo and Cox Communications Extend IP Agreement

TiVo and Cox enter agreement to renew multi-year license to TiVo’s Media Patent Portfolios

SAN JOSE, Calif.–(BUSINESS WIRE)–TiVo®, the company that brings entertainment together and a wholly-owned subsidiary of Xperi Holding Corporation (Nasdaq: XPER) today announced that Cox Communications has entered into a multi-year extension of its intellectual property agreement for the company’s media-related patent portfolios.

As the largest private telecom company in the U.S., Cox is committed to creating meaningful moments of human connection through broadband applications and services. They proudly provide a variety of home and business services to customers across its national footprint, including Contour TV, high-speed internet, Homelife home automation and security, and home phone.

“Our patent license renewal with Cox Communications further confirms the substantial relevance and value of TiVo’s intellectual property portfolios, particularly in the U.S. pay-TV market,” said Samir Armaly, president of intellectual property at Xperi.

TiVo has spent decades investing in research and development to create market-leading technologies and broadly licensing them to the media and entertainment industry. TiVo’s innovations make it easier for viewers to find, watch, and enjoy all their content across a multitude of platforms.

About TiVo

TiVo brings entertainment together, making it easy to find, watch and enjoy. We serve up the best movies, shows and videos from across live TV, on-demand, streaming services and countless apps, helping people to watch on their terms. For studios, networks and advertisers, TiVo delivers a passionate group of watchers to increase viewership and engagement across all screens. In June 2020, TiVo became a wholly-owned subsidiary of Xperi Holding Corporation. Go to tivo.com and enjoy watching.

About Xperi Holding Corporation

Xperi invents, develops, and delivers technologies that enable extraordinary experiences. Xperi technologies, delivered via its brands (DTS, HD Radio, IMAX Enhanced, Invensas, TiVo), and by its startup, Perceive, make entertainment more entertaining, and smart devices smarter. Xperi technologies are integrated into billions of consumer devices, media platforms, and semiconductors worldwide, driving increased value for partners, customers and consumers.

Xperi, DTS, IMAX Enhanced, Invensas, HD Radio, Perceive, TiVo and their respective logos are trademarks or registered trademarks of affiliated companies of Xperi Holding Corporation in the United States and other countries. All other company, brand and product names may be trademarks or registered trademarks of their respective companies.

Source: Xperi Holding Corp

XPER – I

Xperi Investors:

Geri Weinfeld, Vice President Investor Relations

+1 818-436-1231

[email protected]

Xperi Media:

Lerin O’Neill, Director Communications

+1 408-562-8455

[email protected]

KEYWORDS: United States North America California Georgia

INDUSTRY KEYWORDS: Hardware Online Other Communications Consumer Electronics Technology Audio/Video Marketing Advertising General Entertainment Communications TV and Radio Licensing (Entertainment) Other Technology Telecommunications Entertainment Internet

MEDIA:

Posted on

CSG Names Ken Kennedy Chief Operating Officer

CSG Names Ken Kennedy Chief Operating Officer

DENVER–(BUSINESS WIRE)–CSG (NASDAQ: CSGS) today announced it has appointed Ken Kennedy as chief operating officer and president of its Revenue Management and Digital Monetization solutions unit. Previously president of technology and product, Kennedy has dedicated the last 15 years of his career at CSG to leading the company’s product management, engineering, and platform operations across CSG’s solutions portfolio.

“Ken’s innovation and vision has helped CSG become the leading global provider of digital monetization and customer engagement solutions that help our clients compete and thrive in an ever-changing world,” said Brian Shepherd, president and CEO of CSG. “He continues to strengthen our platform-based business model that supports our customers’ most complex business requirements, while delivering agility, flexibility and long-term profitability through cloud-based solutions.”

A forerunner in cloud technology, Kennedy will leverage his expertise to accelerate the growth and development of CSG’s cloud-based software-as-a-service (“SaaS”) platforms and solutions. He will also continue to grow the company’s vast network of ecosystem and systems integrator partners to enhance its holistic approach to solution development.

“The industry is undergoing a tremendous amount of change and transformation. However, CSG’s mission remains the same – to be customer obsessed in our relentless focus to solve their most pressing business challenges,” said Kennedy. “I am honored to be selected for this new role, maintaining my solid commitment to optimizing our customers’ cloud-based go-to-market strategies alongside the industry’s most talented team of technology professionals.”

As president of the Revenue Management and Digital Monetization unit, Kennedy will identify and drive revenue across the company’s different regions, developing products and solutions that deepen CSG’s relationships with its customers to help them solve their toughest business challenges, while fostering growth and innovation across the enterprise.

In addition to his work at CSG, Kennedy brings extensive experience in the BSS/OSS space, product portfolio strategy, SaaS deployment and technology engineering expertise. Kennedy was one of the original founders of Telution, serving as vice president of software development and professional services. He also worked at Andersen Consulting where he developed distributed software solutions for the manufacturing, financial services and communications industries.

About CSG

For more than 35 years, CSG has simplified the complexity of business, delivering innovative customer engagement solutions that help companies acquire, monetize, engage and retain customers. Operating across more than 120 countries worldwide, CSG manages billions of critical customer interactions annually, and its award-winning suite of software and services allow companies across dozens of industries to tackle their biggest business challenges and thrive in an ever-changing marketplace. CSG is the trusted partner for driving digital innovation for hundreds of leading global brands, including AT&T, Charter Communications, Comcast, DISH, Eastlink, Formula One, MTN and Telstra. To learn more, visit our website at csgi.com and connect with us on LinkedIn and Twitter.

Copyright © 2021 CSG Systems International, Inc. and/or its affiliates (“CSG”). All rights reserved. CSG® is a registered trademark of CSG Systems International, Inc. All third-party trademarks, service marks, and/or product names which are referenced in this document are the property of their respective owners, and all rights therein are reserved.

Brad Jones

Global / North America / Asia-Pacific Public Relations

CSG

+1 (303) 200-3001

[email protected]

Kristine Østergaard

CSG

Europe / Middle East / Africa Public Relations

+44 (0)75 0051 8412

[email protected]

John Rea

Investor Relations

CSG

+1 (210) 687 4409

[email protected]

KEYWORDS: Australia/Oceania Australia United States North America Colorado

INDUSTRY KEYWORDS: Professional Services Marketing Data Management Communications Technology Software Consulting

MEDIA:

Posted on

Establishment Labs Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference

Establishment Labs Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference

SANTA BARBARA, Calif.–(BUSINESS WIRE)–
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will participate in the 39th Annual J.P. Morgan Healthcare Conference, which is being held January 11-14, 2021. Mr. Chacón-Quirós is scheduled to speak to conference attendees at 4:30 pm ET on Thursday, January 14, 2021.

A live webcast of the presentation will be available to all interested parties on the Establishment Labs investor relations website at https://investors.establishmentlabs.com/. An archived version of the webcast will be available on the same website following the completion of the event.

About Establishment Labs

Establishment Labs Holdings Inc. is a global medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at our two manufacturing sites that are compliant with ISO13485:2016, FDA 21 CFR 820 under the MDSAP program, and are currently commercially available in more than 80 countries through exclusive distributors or the Company’s direct salesforce. In March 2018, Establishment Labs received approval for an investigational device exemption (IDE) from the FDA and initiated the Motiva Implant® clinical trial in the United States in April 2018. In addition to Motiva Implants®, Establishment Labs’ product and technologies portfolio includes the Divina® 3D Simulation System and other products and services. Please visit our website for additional information at www.establishmentlabs.com.

Investor/Media Contact:

David K. Erickson

949-447-6671

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Oncology Medical Supplies Health Medical Devices Consumer Women Surgery

MEDIA:

Logo
Logo
Posted on

Sesen Bio and Qilu Pharmaceutical Announce IND Application for Vicineum™ Accepted for Review by the National Medical Products Administration in China

Sesen Bio and Qilu Pharmaceutical Announce IND Application for Vicineum™ Accepted for Review by the National Medical Products Administration in China

Clinical trial expected to be initiated shortly after NMPA approval of the IND

Sesen Bio to receive $3M milestone payment upon IND approval

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported that the Investigational New Drug (IND) application submitted to the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) by the Company’s partner in China, Qilu Pharmaceutical, was accepted for review. If the IND is approved, Qilu will be authorized to conduct the proposed clinical trial to assess the efficacy and safety of VicineumTM in patients with non-muscle invasive bladder cancer (NMIBC) in Greater China. The Company’s lead program, Vicineum, also known as VB4-845, is currently in the follow-up stage of a Phase 3 registration trial in the United States (US) for the treatment of high-risk, bacillus Calmette-Guérin (BCG)-unresponsive NMIBC. In December 2020, the Company completed the Biologics License Application (BLA) submission for Vicineum to the FDA.

“The IND submission and acceptance for review by the NMPA for Vicineum in China is a significant milestone for Sesen Bio and our mission of saving and improving the lives of patients with cancer around the world. This accomplishment further highlights the productive collaboration we have with our partner Qilu Pharmaceutical” said Dr. Thomas Cannell, president and chief executive officer of Sesen Bio. “Vicineum is a highly differentiated and potentially best-in-class therapeutic for the treatment of NMIBC. Given the positive Phase 3 trial results achieved in the US and the highly experienced clinical oncology team at Qilu Pharmaceutical, we are optimistic on the prospects for a successful trial. We look forward to continuing to work with Qilu Pharmaceutical and the NMPA to develop and commercialize Vicineum in China.”

The proposed open-label, single-arm, multi-center bridging trial will evaluate the efficacy and safety of Vicineum in approximately 53 patients with carcinoma in situ (CIS) with or without papillary disease, high-grade Ta papillary disease or T1 papillary disease of any grade. Patients will be required to have failed previous treatment with BCG for inclusion in the trial. The primary endpoints are the complete response rate (for CIS patients) and the recurrence-free rate (for papillary patients) at 6 months, with the complete response rate and the recurrence-free rate at 3 months, safety and tolerability as the secondary endpoints.

Upon approval of the IND application by the NMPA, expected in the first half of 2021, Sesen Bio is entitled to receive a $3M milestone payment from Qilu Pharmaceutical, the first of $23M in potential milestone payments. China represents a large potential market for Vicineum, with peak year sales estimated at $155-418M. Furthermore, due to more limited use of BCG in China compared to the US, there is a major opportunity to transform the treatment paradigm of NMIBC in China and save and improve the lives of patients with cancer.

About Vicineum™

Vicineum, a locally administered fusion protein, is Sesen Bio’s lead product candidate being developed for the treatment of high-risk non-muscle invasive bladder cancer (NMIBC). Vicineum is comprised of a recombinant fusion protein that targets epithelial cell adhesion molecule (EpCAM) antigens on the surface of tumor cells to deliver a potent protein payload, Pseudomonas Exotoxin A. Vicineum is constructed with a stable, genetically engineered peptide tether to ensure the payload remains attached until it is internalized by the cancer cell, which is believed to decrease the risk of toxicity to healthy tissues, thereby improving its safety. In prior clinical trials conducted by Sesen Bio, EpCAM has been shown to be overexpressed in NMIBC cells with minimal to no EpCAM expression observed on normal bladder cells. Sesen Bio is currently in the follow-up stage of a Phase 3 registration trial in the US for the treatment of high-risk NMIBC in patients who have previously received a minimum of two courses of bacillus Calmette-Guérin (BCG) and whose disease is now BCG-unresponsive. In December 2020, Sesen Bio completed the BLA submission for Vicineum to the FDA. Additionally, Sesen Bio believes that cancer cell-killing properties of Vicineum promote an anti-tumor immune response that may potentially combine well with immuno-oncology drugs, such as checkpoint inhibitors. The activity of Vicineum in BCG-unresponsive NMIBC is also being explored at the US National Cancer Institute in combination with AstraZeneca’s immune checkpoint inhibitor durvalumab.

About Sesen Bio

Sesen Bio, Inc. is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The Company’s lead program, Vicineum™, also known as VB4-845, is currently in the follow-up stage of a Phase 3 registration trial for the treatment of high-risk, BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). In December 2020, the Company completed the BLA submission for Vicineum to the FDA. Sesen Bio retains worldwide rights to Vicineum with the exception of Greater China and the Middle East and North Africa (MENA), for which the Company has partnered with Qilu Pharmaceutical and Hikma Pharmaceuticals, respectively, for commercialization. Vicineum is a locally administered targeted fusion protein composed of an anti-EpCAM antibody fragment tethered to a truncated form of Pseudomonas Exotoxin A for the treatment of high-risk NMIBC. For more information, please visit the company’s website at www.sesenbio.com.

COVID-19 Pandemic Potential Impact

Sesen Bio continues to monitor the rapidly evolving environment regarding the potential impact of the COVID-19 pandemic on our Company. The Company has not yet experienced any disruptions to our operations as a result of COVID-19, however, we are not able to quantify or predict with certainty the overall scope of potential impacts to our business, including, but not limited to, our ability to raise capital and, if approved, commercialize Vicineum. Sesen Bio remains committed to the health and safety of patients, caregivers and employees.

Cautionary Note on Forward-Looking Statements

Any statements in this press release about future expectations, plans and prospects for the Company, the Company’s strategy, future operations, and other statements containing the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the Company’s ability to successfully develop its product candidates and complete its planned clinical programs, expectations regarding the initiation of Qilu Pharmaceutical’s clinical trial, expectations regarding the proposed clinical trial, expectations regarding the potential market opportunity for Vicineum in Greater China, expectations regarding the potential approval of the IND application by the NMPA in the first half of 2021, expectations regarding the timing and amounts of any milestone payments due under the Company’s license agreement with Qilu Pharmaceutical, expectations regarding the opportunity to transform the treatment paradigm of NMIBC in China, and other factors discussed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the Company’s views as of the date hereof. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date hereof.

Erin Clark, Vice President, Corporate Strategy & Investor Relations

[email protected]

KEYWORDS: Massachusetts China United States North America Asia Pacific

INDUSTRY KEYWORDS: Research Other Health General Health Professional Services Pharmaceutical Oncology Clinical Trials Science Biotechnology FDA Finance Health Other Science

MEDIA:

Logo
Logo
Posted on

Wolters Kluwer adds 2020 BIG Innovation Award to its tally with CCH® Tagetik Smart NOW global expert solutions win

Wolters Kluwer adds 2020 BIG Innovation Award to its tally with CCH® Tagetik Smart NOW global expert solutions win

Adding to a long list of innovation accolades, these cloud-based planning apps provide finance organizations with ready-to-use planning solutions to assess business impact of major market events with agility and confidence

NEW YORK–(BUSINESS WIRE)–
Today, Wolters Kluwer Tax & Accounting announced that its cloud-based CCH® Tagetik Smart NOW global expert solutions were recognized by the Business Intelligence Group as winners in the 2020 BIG Innovation Awards. These innovative financial planning and analysis applications provide the office of the CFO with the agility, real-time information access, and collaborative ability to improve planning and manage economic uncertainty resulting from complex market conditions resulting from events like the current Covid-19 pandemic.

“We are thrilled to be recognized by the Business Intelligence Group for our innovative CCH® Tagetik Smart NOW corporate performance management solutions,” said Ralf Gartner, Senior Vice President and General Manager of Corporate Performance Solutions, Wolters Kluwer Tax & Accounting. “We work side by side with customers and provide expert solutions, expertise, and support so that they can increase confidence in their decision-making process. That is why we developed CCH Tagetik Smart NOW applications, so that more companies can immediately take advantage of these innovative planning capabilities.”

“More than ever, the global society relies on innovation to help progress humanity and make our lives more productive, healthy and comfortable,” said Maria Jimenez, chief operating officer of the Business Intelligence Group. “We are thrilled to be honoring Wolters Kluwer as they are one of the organizations leading this charge and helping humanity progress.”

CCH® Tagetik Smart NOW cloud planning applications were developed to help businesses assess business impact, create alternative scenarios, and choose innovative ways forward. Designed to evolve planning processes to better handle market uncertainty, the new, on-demand apps have been created based on market feedback to provide the capabilities that matter most right now for organizations dealing with turbulent market conditions. These innovative global expert solutions provide organizations with ready to use planning tools for Cash Flow Planning, Driver Based Planning, Risk Adjusted Planning, Workforce Planning, and Capital Expenses Planning.

About Business Intelligence Group

The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, these programs are judged by business executives having experience and knowledge. The organization’s proprietary and unique scoring system selectively measures performance across multiple business domains and then rewards those companies whose achievements stand above those of their peers.

About Wolters Kluwer

Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the healthcare; tax and accounting; governance, risk and compliance; and legal and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.

Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.

MARISA WESTCOTT

212-771-0853

[email protected]

KEYWORDS: New York Europe United States Netherlands North America

INDUSTRY KEYWORDS: Professional Services Data Management Technology Legal Software Finance Accounting

MEDIA:

Logo
Logo
Posted on

Evercore to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 3, 2021

Evercore to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 3, 2021

NEW YORK–(BUSINESS WIRE)–
Evercore (NYSE: EVR) will release its fourth quarter and full year 2020 financial results on Wednesday, February 3, 2021. Evercore will host a related conference call, accessible via telephone and the internet, beginning at 8:00 a.m. Eastern Time that same day.

Evercore’s Co-Chairmen and Co-Chief Executive Officers, Ralph L. Schlosstein and John S. Weinberg, and Chief Financial Officer, Robert B. Walsh, will review the Firm’s fourth quarter and full year 2020 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour.

Investors and analysts may participate in the live conference call by dialing (877) 359-9508 (toll-free domestic) or (224) 357-2393 (international); passcode: 8631259. Please register at least 10 minutes before the conference call begins. A replay of the call will be available for one week via telephone starting approximately one hour after the call ends. The replay can be accessed at (855) 859-2056 (toll-free domestic) or (404) 537-3406 (international); passcode: 8631259. A live audio webcast of the conference call will be available on the For Investors section of Evercore’s website at www.evercore.com. The webcast will be archived on Evercore’s website for 30 days.

About Evercore

Evercore (NYSE: EVR) is a premier global independent investment banking advisory firm. We are dedicated to helping our clients achieve superior results through trusted independent and innovative advice on matters of strategic significance to boards of directors, management teams and shareholders, including mergers and acquisitions, strategic shareholder advisory, restructurings, and capital structure. Evercore also assists clients in raising public and private capital and delivers equity research and equity sales and agency trading execution, in addition to providing wealth and investment management services to high net worth and institutional investors. Founded in 1995, the Firm is headquartered in New York and maintains offices and affiliate offices in major financial centers in the Americas, Europe, the Middle East and Asia. For more information, please visit www.evercore.com.

Investor:

Hallie Elsner Miller

Head of Investor Relations, Evercore

+1.917.386.7856

Media:

Dana Gorman

Abernathy MacGregor, for Evercore

+1.212.371.5999

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo
Posted on

TAAL President Chris Naprawa to Present at Noble Capital Markets’ Seventeenth Annual Investor Conference

PR Newswire

VANCOUVER,BC, Jan. 13, 2021 /PRNewswire/ – TAAL Distributed Information Technologies Inc. (CSE:TAAL) (FWB:9SQ1) (OTC:TAALF) (“TAAL” or the “Company”) a vertically integrated, blockchain infrastructure and service provider for enterprise clients, today announced that its President, Chris Naprawa will present at NobleCon17 – Noble Capital Markets’ Seventeenth Annual Investor Conference on Tuesday January 19th at 3:00 p.m. (EST). The conference will be held virtually, with no cost, obligation or restrictions to attend, at: www.noblecon17.com

A high-definition video webcast of the presentation will be available the following day on www.TAAL.com and as part of a complete catalog of presentations expected to be rebroadcast on Channelchek www.channelchek.com next month.

TAAL Highlights:

  • TAAL is the only publicly traded company that is building blockchain processing solutions for a growing global enterprise market focused exclusively on Bitcoin SV (“BSV”).
  • TAAL has strengthened its capacity as a leader in the growing global BSV blockchain network with highly experienced additions to its board, executive and management team.
  • Recently purchased new blockchain computers representing over 130 petahash (“PH”) in additional computing power, bringing the Company’s overall computing capacity to more than 280 PH.
  • TAAL is focused on assembling the transaction processing and indexing infrastructure, software, and services to be a global leader on the BSV blockchain in a data driven economy in which Gartner predicts that at least 25% of the Forbes Global 2000 will use blockchain as a foundation for digital trust at scale in 20211.

About TAAL Distributed Information Technologies Inc.

TAAL Distributed Information Technologies Inc. delivers value-added blockchain services, providing professional-grade, highly scalable blockchain infrastructure and transactional platforms to support businesses building solutions and applications upon the BSV platform, and developing, operating, and managing distributed computing systems for enterprise users. The Company is led by an experienced management team, Board and Advisory Board members that include entrepreneur and BSV advocate Calvin Ayre, and renowned computer scientist Craig Wright.

Visit TAAL online at www.taal.com

1
https://www.gartner.com/en/information-technology/insights/blockchain  

About Noble Capital Markets, Inc.
Noble Capital Markets (“Noble”) is a research driven boutique investment bank that has supported small & microcap companies since 1984. As a FINRA and SEC licensed and registered broker-dealer Noble provides institutional-quality equity research, merchant and investment banking, wealth management and order execution services. In 2005, Noble established NobleCon, an investor conference that has grown substantially over the last decade+. In 2018 Noble launched www.channelchek.com – an investment community dedicated exclusively to small and micro-cap companies and their industries. Channelchek is tailored to meet the needs of self-directed investors and financial professionals and is the first service to offer institutional-quality research to the public, for FREE at every level without a subscription. More than 6,000 emerging growth companies are listed on the site, with growing content including webcasts, industry sector reports, advanced market data and balanced news.

The CSE, nor its Regulation Services Provider, accepts no responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Certain statements included in this news release constitute “forward-looking information” as defined under applicable Canadian securities legislation. The words “will”, “intends”, “expects” and similar expressions are intended to identify forward-looking information, although not all forward-looking information will contain these identifying words. Specific forward-looking information contained in this news release includes but is not limited to statements regarding: Noble’s Seventeenth Annual Investor Conference, and related video webcasts; TAAL’s intention to deliver BSV blockchain transaction processing and indexing infrastructure, software and services to a growing global enterprise market and to become a consistently performing leader in the adoption of the growing global BSV blockchain network; and blockchain adoption by Forbes Global 2000. These statements are based on factors and assumptions related to historical trends, current conditions and expected future developments. Since forward-looking information relates to future events and conditions, by its very nature it requires making assumptions and involves inherent risks and uncertainties. TAAL cautions that although it is believed that the assumptions are reasonable in the circumstances, these risks and uncertainties give rise to the possibility that actual results may differ materially from expectations. Material risk factors include the future acceptance of BSV and other digital assets and risks related to information processing using those platforms, the ability for TAAL to leverage intellectual property into viable income streams and other risks set out in Item 20 Risk Factors of TAAL’s Form 2A – Listing Statement dated July 31, 2018 and elsewhere in TAAL’s continuous disclosure filings available on SEDAR at www.sedar.com. Given these risks, undue reliance should not be placed on the forward-looking information contained herein. Other than as required by law, TAAL undertakes no obligation to update any forward-looking information to reflect new information, subsequent or otherwise.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/taal-president-chris-naprawa-to-present-at-noble-capital-markets-seventeenth-annual-investor-conference-301207087.html

SOURCE Taal Distributed Information Technologies Inc.

Posted on

GreenFirst Announces Strategic Review by 1347 Investors LLC of its Surplus Real Estate Assets

Canada NewsWire

VANCOUVER, BC, Jan. 13, 2021 /CNW/ – GreenFirst Forest Products Inc (TSXV: GFP) (“GreenFirst” or the “Company“), is pleased to announce that 1347 Investors LLC (“1347 LLC“), one of its investee companies, has initiated a strategic review process to explore and evaluate a broad range of alternatives to increase and maximize shareholder value with respect to its real estate assets following its acquisition of the sawmill and related surplus lands located in Kenora, Ontario.

Following the acquisition of the sawmill on October 6, 2020, 1347 LLC owns 118 acres of land on the northern shore of Lake of the Woods in the town of Kenora, Ontario, including a four-acre island in Keewatin Bay and approximately one kilometer of mainland shoreline. As part of the strategic review process, 1347 LLC intends to explore ways to maximize the future operations of the sawmill along with the development potential of the surplus lands with various stakeholders.

1347 LLC has advised the Company that it has not made any decisions related to strategic alternatives at this time and there can be no assurance that the evaluation of strategic alternatives will result in any transaction or change in strategy. No timeline for completion of the strategic review process has currently been defined by 1347 LLC. The Company does not intend to comment further unless and until the board of directors of 1347 LLC has approved a specific course of action or the Company has determined that further disclosure is appropriate or necessary.

Forward Looking Information

Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact are forward-looking statements. Forward looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend”, “estimate” or the negative of these terms and similar expressions.

Forward-looking statements in this news release include, but are not limited to statements regarding 1347 LLC’s strategic review process. Forward-looking statements are based on certain assumptions and, while the Company considers these assumptions to be reasonable, based on information currently available, they may prove to be incorrect. In addition, forward-looking statements necessarily involve known and unknown risks, including, without limitation, that the strategic review may not enhance shareholder value; and that the strategic review may not be completed within a reasonable timeframe, or at all. Readers are cautioned that the foregoing list is not exhaustive and other risks are set out in the Company’s public disclosure record filed under the Company’s profile on www.sedar.com. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof, and thus are subject to change thereafter. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE Itasca Capital Ltd.

Posted on

Hello Pal Year In Review: 900% Revenue Growth in 2020

Livestreaming Business Propels Significant Growth

PR Newswire

VANCOUVER, British Columbia, Jan. 13, 2021 /PRNewswire/ — Hello Pal International Inc. (“Hello Pal” or the “Company”) (CSE:HP Frankfurt:27H OTC:HLLPF), a provider of rapidly growing international live-streaming, social messaging and language learning mobile apps, is pleased to recap its performance over the year 2020, with a highlight being that it experienced a growth in monthly revenue of over 900% over the course of last year.

After integrating livestreaming services into its international social networking platform in 2019 and generating revenues in the middle of that year, the Company’s monthly revenue climbed to RMB1,000,000(CAD 200,000) in January 2020.  By the end of the year, it had risen to over RMB 10,848,000 (CAD 2.1 million) for December 2020, representing an increase of over 900%.  In total, the Company achieved a total revenue of RMB60,000,000 (CAD 10.2 million) for the entire year.  Furthermore, the Company achieved strong cash flow over the year, which exceeded its ongoing operating costs.

In addition, the Company started to increase its service offerings beyond livestreaming, and launched a 1-on-1 live video matching service towards the end of last year.  At the same time, the Company expanded its revenue model by introducing its VIP monthly subscription service, where users can subscribe to be VIP members in order to enhance their experience on the Hello Pal platform.

“It feels really rewarding to see the work we’ve put in back in 2019 pay off the following year,” said KL Wong, Chairman and CEO of the Company.  “We’ve continued to lay the foundation for future growth last year with our video matching service and new revenue model, and we look forward to reaping its benefits this year.”

To download Hello Pal please visit the IOS or Android store. For information with respect to the Company or the contents of this news release, please contact the Company at (604) 683-0911 or visit the website at hellopal.com. Email inquiries can be directed to: [email protected].

About the Hello Pal Platform

The Hello Pal Platform is a proprietary suite of mobile applications built on a user-friendly messaging interface that focus on social interaction, language learning and travel. Hello Pal, has been designed from the ground up to be easy to use and enables users’ the freedom to speak in their own language regardless of the other person’s language they are speaking to. Hello Pal’s overriding mission is to bring the world closer together through social interaction, language learning and travel. By creating a platform where it is easy to instantly interact with others around the world and giving them the tools to communicate with each other in a joyful and fun way, we hope to do our part (however small) in fostering understanding and tolerance between all citizens of the world.

Information set forth in this news release contains forward-looking statements. These statements reflect management’s current estimates, beliefs, intentions, and expectations; they are not guarantees of future performance. Hello Pal cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Hello Pal’s control. Such risks and uncertainties are described in Hello Pal’s annual and interim financial statements available on www.sedar.com. Although Hello Pal is currently generating revenues, Hello Pal remains in the growth stage and such revenues are yet to be profitable.  Accordingly, actual, and future events, conditions and results may differ materially from the estimates, beliefs, intentions, and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Hello Pal undertakes no obligation to publicly update or revise forward-looking information.

THE CSE HAS NEITHER APPROVED NOR DISAPPROVED THE INFORMATION CONTAINED HEREIN AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE


Hello Pal International


www.hellopal.com


p 604-683-0911

 

Cision View original content:http://www.prnewswire.com/news-releases/hello-pal-year-in-review-900-revenue-growth-in-2020-301207031.html

SOURCE Hello Pal International Inc.

Posted on

Namaste Technologies Continues Upward Revenue Trend, Reporting Estimated Q4 Revenue and Fiscal 2020

PR Newswire

  • Anticipates quarterly gross revenue, including cannabis revenue, of approximately $8.0 million in Q4 2020; a year-over-year increase of 100% from $4.0 million in Q4 2019 and a quarter-over-quarter increase of 21% from $6.3 million in Q3 2020
  • Anticipates annual gross revenue, including cannabis revenue, of approximately $27 million in fiscal 2020; a year-over-year increase of 59% from $16 million in fiscal 2019

TORONTO, Jan. 13, 2021 /PRNewswire/ – Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF), a leading platform for cannabis products, accessories, and education, today reported its estimated revenue for the fourth quarter 2020 and fiscal 2020 ended November 30, 2020.  Namaste expects to release the Company’s audited fourth quarter and annual financial results on or before March 30, 2021.

The Company anticipates that gross revenue for the fourth quarter 2020 will be approximately $8.0 million, an increase of approximately 100% over Q4 2019 revenue of $4.0 million, thereby expecting to nearly double revenue quarter-over-quarter, and is representing an approximately 21% increase over Q3 2020 revenue of $6.3 million.  Namaste is targeting continued revenue growth throughout 2021 as we move to complete the integration of CannMart Labs and bring new and higher-margin products which will be introduced through new brand lines starting with “Roilty”.    

“We are very pleased by the hard work of the team who doubled the revenue growth over the fourth quarter of 2019,” said Meni Morim, CEO of Namaste. “We believe our preliminary results demonstrate the strength of our business during an inflection point within the industry.  Namaste as an organization is relentlessly focussed on the execution of our strategy to become a leading global cannabis company.”

See “Forward-Looking Information” below for assumptions and risks.

The Company will release its audited annual financial results for the fiscal year ended November 30, 2020 on or before March 30, 2021.

Financial Disclaimer:

The preliminary estimated financial results and other data for the three months and year ended November 30, 2020 set forth above are subject to the completion of the Company’s financial closing procedures.  This data has been prepared by, and is the responsibility of, the Company’s management and audit committee.  Namaste independent registered public accounting firm, Baker Tilly LLP, is in the process of performing year-end audit procedures with respect to these preliminary financial results and other data, and accordingly does not express an opinion or any other form of assurance with respect thereto.  The Company currently expects that its final results of operations and other data will be consistent with the estimates set forth above, but such estimates are preliminary and Namaste actual results of operations and other data could differ materially from these estimates due to the completion of its fiscal year-end audit procedures, final adjustments, and other developments that may arise between now and the time such annual audited consolidated financials statements for the twelve months ended November 30, 2020 are released.

About Namaste Technologies Inc.

Headquartered in Toronto, Canada, Namaste Technologies is a leading online platform for cannabis products, accessories, and responsible education. The Company’s ‘everything cannabis store’, CannMart.com, provides medical customers with a diverse selection of hand-picked products from a multitude of federally licensed cultivators, all on one convenient site. The Company also distributes licensed and in-house branded cannabis and cannabis derived products to recreational consumers in Canada through a number of provincial government control boards and retailing bodies and facilitates licensed cannabis retailer sales online in Saskatchewan. Namaste’s global technology and continuous innovation address local needs in a burgeoning cannabis industry requiring smart solutions.

Information on the Company and its many products can be accessed through the links below:


NamasteTechnologies.com


NamasteMD.com


Cannmart.com

FORWARD-LOOKING INFORMATION – This news release contains “forward-looking information” within the meaning of applicable securities laws. These statements may relate to anticipated events or results and include, but are not limited to,  statements related to the Company’s anticipated revenue, i for the quarter and year ended November 30, 2020 and the Company’s ability to bring new and higher-margin products and brands to market to generate additional material revenue in the future and other statements that are not historical facts.  Forward-looking information relating to the Company’s anticipated revenues is strictly provided as financial guidance to investors as prepared by management and may not be appropriate for any other purpose, and remains subject to the audited financial statements of the Company and related MD&A for the year ended November 30, 2020 to be released on or prior to March 30, 2021. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as “may”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen. The forward-looking information contained herein is made as of the date of this press release and is based on assumptions management believed to be reasonable at the time, including, without limitation, audited financial results being in line with preliminary financial results reviewed by management, the expectation that the introduction of new products and brands will generate additional revenue,  Namaste’s standing in the online marketplace for cannabis and related products and accessories, Namaste’s beliefs regarding the expected demand for cannabis and related products and accessories and the expected growth of that market, results of operations, operational matters, historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release. Such factors include, without limitation: regulatory risk, risks relating to the Company’s ability to execute its business strategy and the benefits realizable therefrom and risks specifically related to the Company’s operations. Additional risk factors can also be found in the Company’s current MD&A and annual information form, both of which have been filed under the Company’s SEDAR profile at www.sedar.com. Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/namaste-technologies-continues-upward-revenue-trend-reporting-estimated-q4-revenue-and-fiscal-2020-301207266.html

SOURCE Namaste Technologies Inc.